Promoter attenuation in gene therapy: Interferon-γ and tumor necrosis factor-α inhibit transgene expression

Human Gene Therapy

Volumn 8, Issue 17, 1997, Pages 2019-2029

  Qin, Lihui ^a   Ding, Yaozhong ^a   Pahud, Dominique R ^a   Chang, Eugenia ^a,b   Imperiale, Michael J ^a   Bromberg, Jonathan S ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLONING VECTOR; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA DEGRADATION; ENHANCER REGION; GENE THERAPY; GENE TRANSFER; HUMAN; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PROMOTER REGION; ROUS SARCOMA ONCOVIRUS; SIMIAN VIRUS 40; TRANSGENE; VIRUS ATTENUATION;

EID: 0031581174     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.17-2019     Document Type: Article

References (8)

1. ALONSO, S., MINTY, A., BOURLET, Y., and BUCKINGHAM, M.E. (1986). Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J. Mol. Evol. 23, 11-22.
2. BARR, D., TUBE, J., FERGUSON, D., SCARIA, A., LIEBER, A., WILSON, C., PERKINS, J., and KAY, M.A. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
3. CHALLITA P.M., and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91, 2567-2571.
4. CHU, Y., SPERBER, K., MAYER, L., and HSU, M.T. (1992). Persistent infection of human adenovirus type 5 in human monocyte cell lines. Virology 188, 793-800.
5. CRYSTAL, R.G. (1995). The gene as the drug. Nat. Med. 1, 15-17.
6. CSETE, M.E., DRAZAN, K.E., BREE, M.V., and SHAKED, A. (1994). Adenovirus-mediated gene transfer in the transplant setting. Part I: Conditions for expression of transferred genes in cold preserved hepatocytes. Transplant 57, 1502-1507.
7. DAI, Y., SCHWARTZ, E.M., GU, D., ZHANG, W.W., SARVET-NICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
8. DEMATTEO, R.P., RAPER, S.E., AHN, M., FISHER, K.J., BURKE, C., RADU, A., WIDERA, G., CLAYTON, B.R., BARKER, C.F., and MARKMANN, J.F. (1955). Gene transfer to the thymus: A means of abrogating the immune response to recombinant adenovirus. Annals Surg. 222, 229-242.